Q0515 Sermorelin acetate injection
Also known as: Geref, sermorelin, GRH analog
Sermorelin acetate injection, a synthetic growth hormone-releasing hormone used to stimulate growth hormone secretion.
In Plain Language
growth hormone stimulator; injection therapy
Clinical Context
Used to evaluate and treat growth hormone deficiency in children and adults. Stimulates endogenous growth hormone release through hypothalamic mechanism.
RVU Information
CPT Q0515 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q0515?
CPT Q0515 (Sermorelin acetate injection) is a Q Codes code. Sermorelin acetate injection, a synthetic growth hormone-releasing hormone used to stimulate growth hormone secretion.
Is Q0515 covered by insurance?
Q0515 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used to evaluate and treat growth hormone deficiency in children and adults. Stimulates endogenous growth hormone release through hypothalamic mechanism.
When is CPT Q0515 used?
Used to evaluate and treat growth hormone deficiency in children and adults. Stimulates endogenous growth hormone release through hypothalamic mechanism.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.